Lagano Roxanne

Avg. Two Year Performance

No purchase track record
(22%) Avg. Sale Return
(10%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)(5%)(7%)(9%)(22%)
Sale Success Rate7 of 263 of 261 of 260 of 260 of 26
Drugs » Drug Manufacturers - Major

Executive Vice President:

Holdings: 15.6K shares

Sentiment

Insider Trading Sentiment: Sell

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($776.83K) Net Amount
Buy:0--
Sell:($776.83K)$186.86 - $197.74